跳至主要内容
临床试验/EUCTR2018-000407-16-FR
EUCTR2018-000407-16-FR进行中(未招募)1 期

Prospective multicenter randomized double-blind study comparing caspofungin to placebo for the treatment of ICU yeast intra-abdominal infection - CASPER

CHU Amiens-Picardie0 个研究点目标入组 448 人开始时间: 2018年11月6日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
448

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Age = 18 years old
  • Covered by national health insurance
  • Admitted to ICU after surgery for intra-abdominal infection :
  • -With suspected intra-abdominal candidiasis defined by a Peritonitis score = 3(1)
  • -Or with documented intra-abdominal candidiasis defined by positive direct examination or positive culture of peritoneal fluid collected intraoperatively.
  • With written and signed informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 298
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 149

排除标准

  • Allergy to caspofungin
  • Life expectancy = 48h
  • Expected withdrawal of treatment
  • Radiological drainage without surgery
  • Severe hepatic impairment (Child-Pugh C score)
  • Pregnant or lactating women

研究者

发起方
CHU Amiens-Picardie

相似试验